Navigation Links
ResMed Wins Initial Decision in ITC Patent Infringement Action
Date:8/24/2014

SYDNEY and SAN DIEGO, Aug. 24, 2014 /PRNewswire/ -- An administrative law judge at the International Trade Commission (ITC) ruled Friday August 22 in a patent infringement case brought by ResMed (NYSE: RMD) against Chinese medical device manufacturer BMC Medical Co., Ltd., that each of nine BMC products named in the action infringes one or more ResMed patents.  As a result, ITC Judge Thomas Pender recommended that the ITC ban BMC and its U.S. distributor, 3B Medical, from importing or selling any of the infringing BMC products in the United States.  Judge Pender also recommended a cease and desist order that would enjoin BMC and 3B from selling, advertising, marketing, storing or testing the infringing products in the United States.  ResMed is the innovation leader and pioneer in designing and manufacturing devices for the treatment of sleep-disordered breathing.

Judge Pender found that BMC's InH2 humidifier, as well as original and redesigned versions of the following BMC masks infringe ResMed's patents:

  • iVolve nasal mask
  • iVolve N2 nasal mask
  • Willow nasal pillows mask
  • iVolve full face mask
  • "The Judge's decision is not just a victory for ResMed and the product innovation that is core to our brand, but it's also a win for patients who deserve high quality, comfortable care," said David Pendarvis, ResMed chief administrative officer and global general counsel. "We will continue innovating and continue protecting our intellectual property anywhere we identify infringement."

    About ResMed:
    ResMed changes lives by developing, manufacturing and distributing medical equipment for treating, diagnosing, and managing sleep-disordered breathing, COPD, and other chronic diseases. We develop innovative products and solutions to improve the health and quality of life of those who suffer from these conditions, and we work to raise awareness of the potentially serious health consequences of untreated sleep-disordered breathing. For more information on ResMed, visit www.resmed.com.Contacts: For News Media For InvestorsGretchen Griswold

    Agnes LeeDirector, Global Corporate Communications

    Senior Director, Investor RelationsO: 858-836-6789

    O: 858-836-5971news@resmed.com 

    investorrelations@resmed.comLogo - http://photos.prnewswire.com/prnh/20140310/LA79234LOGO-a


    '/>"/>
    SOURCE ResMed
    Copyright©2014 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. ResMed Inc. Announces Plan To Initiate Dividend And Update On Chief Executive Officer Succession
    2. ResMed Launches Narval™ CC Mandibular Repositioning Device in the US
    3. ResMed Announces Conference Call And Webcast To Discuss Fourth Quarter And Fiscal Year-End 2012 Results
    4. ResMed Inc. Announces Record Financial Results For The Quarter And Twelve Months Ended June 30, 2012
    5. ResMed Inc. Announces Record Financial Results for the Quarter Ended September 30, 2012
    6. ResMed Inc. Announces Exchange Rate For Upcoming Dividend Payment
    7. ResMed Inc. Announces Record Financial Results For The Quarter Ended And Six Months Ended December 31, 2012
    8. Buoyed by Forecasts, Where 2013 Leads - Research Report on ResMed Inc., Zimmer Holdings, Inc., Waters Corporation, Covidien PLC, and Medtronic, Inc.
    9. ResMed Takes Action to Enforce Patents
    10. ResMed Announces Conference Call And Webcast To Discuss Third Quarter 2013 Results
    11. ResMed Noninvasive Ventilation Device Cleared by FDA for COPD Treatment
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/24/2016)... OAKLAND, N.J. , June 24, 2016 /PRNewswire/ ... in the design, development and manufacturing of collagen ... and regeneration announced today that Bill Messer ... Sales and Marketing to further leverage the growing ... surgery medical devices. Bill joins the ...
    (Date:6/24/2016)... Va. , June 24, 2016 The ... set of recommendations that would allow biopharmaceutical ... (HCEI) with entities that make formulary and coverage decisions, ... the "value" of new medicines. The recommendations ... does not appear on the drug label, a prohibition ...
    (Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
    Breaking Medicine Technology:
    (Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now ... of Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. ... Final Cut Pro X users can now reveal the media of their split ...
    (Date:6/27/2016)... , ... June 27, 2016 ... ... the patient payment industry today announced its strategic partnership with Connance, a ... workflows. , The two companies’ proven, proprietary technology combine to provide health ...
    (Date:6/27/2016)... Park, KS (PRWEB) , ... June 27, 2016 , ... ... in retailers of Eyeglasses . , Millions of individuals in the United States ... eyeglasses have become a way to both correct vision and make a fashion statement. ...
    (Date:6/26/2016)... ... 2016 , ... On June 10-11, 2016, A Forever Recovery, a holistic treatment ... Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. This ... of the world’s leading providers of cereal and other breakfast foods. Its residents often ...
    (Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
    Breaking Medicine News(10 mins):